News | Radiation Dose Management | June 21, 2017

RadNet will employ Medic Vision’s CT Dose reduction and XR-29 compliance products in its facilities as well as helping develop future products

RadNet Inc. Acquires Equity Stake in Medic Vision

June 21, 2017 — RadNet Inc. and Medic Vision Imaging Solutions Ltd. announced that RadNet has acquired an equity stake in Medic Vision.

This investment comes after both parties announced last summer that RadNet will use Medic Vision's CT [computed tomography] Dose reduction and management and XR-29 compliance products in numerous facilities. The companies also added that they will join forces in the development and validation of Medic Vision’s future products.

“We are highly impressed by the quality of the technology, products and services that Medic Vision provides, as well as the company's roadmap for future offerings,” said Howard Berger, M.D., CEO, RadNet. “We identified the significant technical progress and leadership Medic Vision has demonstrated throughout the years, and believe that combined with our experience, knowledge and expertise, Medic Vision can accelerate its growth and innovation,” added Dr. Berger.

“Since we started collaborating with RadNet, we recognized the importance and effectiveness of our products and services to RadNet’s services and to that of the rest of the imaging industry,” explained Eyal Aharon, CEO, Medic Vision.  

“We are honored to have a leading company like RadNet as a shareholder. The trust and confidence RadNet has shown in our products and services build a strong foundation for future product development,” said Eyal Aharon, CEO, Medic Vision.

For more information: www.radnet.com, www.medicvision.com


Related Content

Feature | Radiation Oncology

The radiation oncology community lost a leader this past summer, with the passing of Jay Loeffler, MD, FACR, FASTRO. He ...

Time September 21, 2023
arrow
Feature | Radiation Dose Management | By Melinda Taschetta-Millane

Early-stage detection is key to the prevention of life-threatening diseases; however, limited access to data hinders the ...

Time September 20, 2023
arrow
News | Artificial Intelligence

September 20, 2023 — Medical imaging artificial intelligence (AI) company Annalise.ai has announced that the results ...

Time September 20, 2023
arrow
News | Radiation Therapy

September 20, 2023 — RefleXion Medical, Inc., a therapeutic oncology company and 3B Pharmaceuticals (3BP) GmbH, a ...

Time September 20, 2023
arrow
Sponsored Content | Case Study | Radiology Imaging | By Tim Hodson

In June, the Philips Radiology Experience Tour hit the road to provide healthcare professionals with an opportunity to ...

Time September 19, 2023
arrow
News | FDA

September 13, 2023 — Annalise.ai, a leader in AI-powered medical imaging solutions, announced the receipt of 510(k) ...

Time September 13, 2023
arrow
News | Radiation Oncology

September 13, 2023 — Intensity-modulated radiation therapy (IMRT) should be the preferred choice when treating patients ...

Time September 13, 2023
arrow
News | RSNA

September 12, 2023 — The Radiological Society of North America (RSNA) launched “RSNA Market Insights,” a series of ...

Time September 12, 2023
arrow
News | Radiation Oncology

September 12, 2023 — Michael J. Zelefsky, MD, a renowned leader in radiation oncology, is joining NYU Langone’s ...

Time September 12, 2023
arrow
News | Artificial Intelligence

September 12, 2023 — Medical imaging Artificial Intelligence (AI) company Qure.ai has announced a pivotal 510(k) ...

Time September 12, 2023
arrow
Subscribe Now